购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

GSK256066 Trifluoroacetate

产品编号 T11483Cas号 1415560-64-3
别名 GSK 256066 Trifluoroacetate, GSK256066 (2,2,2-trifluoroacetic acid)

GSK 256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor (IC50: 3.2 pM for PDE4B). It can be used for the treatment of chronic obstructive pulmonary disease.

GSK256066 Trifluoroacetate

GSK256066 Trifluoroacetate

纯度: 无数据
产品编号 T11483 别名 GSK 256066 Trifluoroacetate, GSK256066 (2,2,2-trifluoroacetic acid)Cas号 1415560-64-3

GSK 256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor (IC50: 3.2 pM for PDE4B). It can be used for the treatment of chronic obstructive pulmonary disease.

规格价格库存数量
2 mg¥ 6925日内发货
5 mg¥ 1,2405日内发货
25 mg¥ 4,2801-2周
50 mg¥ 5,5701-2周
100 mg¥ 8,5801-2周
大包装 & 定制
加入购物车
实验操作小课堂
查看更多
联系我们获取更多批次信息
资源下载
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
GSK 256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor (IC50: 3.2 pM for PDE4B). It can be used for the treatment of chronic obstructive pulmonary disease.
靶点活性
PDE4B:3.2 pM
体外活性
GSK 256066 Trifluoroacetate is highly selective for PDE4, with >380,000-fold versus PDE1/2/3/5/6 and >2500-fold against PDE7, and inhibits PDE4 isoforms A-D with equal affinity.?GSK 256066 Trifluoroacetate inhibits tumor necrosis factor α production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes with IC50 of 0.01 nM.GSK 256066 Trifluoroacetate ?is an exceptionally high-affinity inhibitor of PDE4 designed for inhaled administration.
体内活性
GSK 256066 Trifluoroacetate inhibits LPS-induced pulmonary neutrophilia, and no emetic episodes are observed in ferrets.GSK 256066 Trifluoroacetate (GSK256066 2,2,2-trifluoroacetic acid; 0.3-100 μg/kg; intratracheally) inhibits the eosinophil number increased in the bronchoalveolar lavage (BAL) in a dose-dependent fashion, in lipopolysaccharide (LPS)- and ovalbumin (OVA)-induced acute pulmonary inflammation rat models.
别名GSK 256066 Trifluoroacetate, GSK256066 (2,2,2-trifluoroacetic acid)
化学信息
分子量632.61
分子式C29H27F3N4O7S
CAS No.1415560-64-3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 50 mg/mL (79.04 mM), Sonication is recommended.
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM1.5808 mL7.9038 mL15.8075 mL79.0376 mL
5 mM0.3162 mL1.5808 mL3.1615 mL15.8075 mL
10 mM0.1581 mL0.7904 mL1.5808 mL7.9038 mL
20 mM0.0790 mL0.3952 mL0.7904 mL3.9519 mL
50 mM0.0316 mL0.1581 mL0.3162 mL1.5808 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy GSK256066 Trifluoroacetate | purchase GSK256066 Trifluoroacetate | GSK256066 Trifluoroacetate cost | order GSK256066 Trifluoroacetate | GSK256066 Trifluoroacetate chemical structure | GSK256066 Trifluoroacetate in vivo | GSK256066 Trifluoroacetate in vitro | GSK256066 Trifluoroacetate formula | GSK256066 Trifluoroacetate molecular weight